Showing 1-10 of 32 grants

Title Institution Researcher Program Duration Total Award Amount
Unraveling the Mechanisms of HLA-DQ8 Graft Acceptance: Insights from the Largest Single Cohort of Islet Transplant Recipients in the Edmonton Program The University of Edinburgh Shareen Forbes Cures 01-October-2025 to 30-September-2027 $749.938,79
Investigating and Optimising the translational potential of NAMPT inhibition in type 1 diabetes King's College London Paul Caton Cures 01-November-2025 to 31-October-2028 $859.147,00
Defining metabolic dysfunction and use of adjunct therapies in type 1 diabetes, using real-world data Imperial College London Shivani Misra Improving Lives 01-October-2025 to 30-September-2027 $701.005,42
Enhancing Breakthrough T1D strategy around treatment development with cures on the horizon PA Consulting Paolo Siciliano Improving Lives 01-July-2025 to 24-November-2025 $662.626,27
Understanding the impact of endogenous insulin secretion on clinical outcomes in type 1 diabetes and the optimal approach to C-peptide measurement for outcome prediction University of Exeter Angus Jones Cures 01-June-2025 to 31-May-2027 $581.477,00
Unlocking the translational potential of extreme forms of autoimmune diabetes by uncovering heterogeneous mechanisms of beta-cell autoimmunity University of Exeter Matthew Johnson Cures 01-April-2024 to 31-March-2029 $335.110,00
Digital Resources for India – Pilot Project Digibete John Hughes Improving Lives 01-March-2025 to 29-February-2028 $213.785,00
Profiling The Kinome In Type 1 Diabetes; Identifying Novel Targets For Biomarker Development and Disease-modifying Therapies University of Bristol Anna Long Cures 01-April-2025 to 31-March-2026 $197.076,23
Are we missing something – do the small things matter? University of Exeter Sarah Richardson Cures 01-May-2025 to 30-April-2028 $994.000,00
Establishing the effectiveness, safety and acceptability of treatments to preserve beta cell function in people with type 1 diabetes (T1D) University of Birmingham Parth Narendran Cures 01-September-2024 to 31-August-2027 $279.997,78